Janux Therapeutics Inc (JANX)
62.60
-2.18
(-3.37%)
USD |
NASDAQ |
May 06, 13:50
Janux Therapeutics Market Cap: 3.234B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.347B |
| May 02, 2024 | 3.225B |
| May 01, 2024 | 3.006B |
| April 30, 2024 | 2.945B |
| April 29, 2024 | 2.897B |
| April 26, 2024 | 2.448B |
| April 25, 2024 | 2.433B |
| April 24, 2024 | 2.491B |
| April 23, 2024 | 2.572B |
| April 22, 2024 | 2.525B |
| April 19, 2024 | 2.515B |
| April 18, 2024 | 2.524B |
| April 17, 2024 | 2.478B |
| April 16, 2024 | 2.611B |
| April 15, 2024 | 2.679B |
| April 12, 2024 | 2.720B |
| April 11, 2024 | 2.583B |
| April 10, 2024 | 2.305B |
| April 09, 2024 | 2.068B |
| April 08, 2024 | 1.996B |
| April 05, 2024 | 1.814B |
| April 04, 2024 | 1.829B |
| April 03, 2024 | 1.877B |
| April 02, 2024 | 1.853B |
| April 01, 2024 | 1.947B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.945B |
| March 27, 2024 | 1.959B |
| March 26, 2024 | 2.006B |
| March 25, 2024 | 1.990B |
| March 22, 2024 | 2.042B |
| March 21, 2024 | 2.059B |
| March 20, 2024 | 2.021B |
| March 19, 2024 | 1.996B |
| March 18, 2024 | 2.005B |
| March 15, 2024 | 2.038B |
| March 14, 2024 | 1.951B |
| March 13, 2024 | 2.062B |
| March 12, 2024 | 2.006B |
| March 11, 2024 | 2.065B |
| March 08, 2024 | 2.057B |
| March 07, 2024 | 2.098B |
| March 06, 2024 | 2.173B |
| March 05, 2024 | 2.188B |
| March 04, 2024 | 2.156B |
| March 01, 2024 | 2.205B |
| February 29, 2024 | 2.238B |
| February 28, 2024 | 2.155B |
| February 27, 2024 | 2.301B |
| February 26, 2024 | 698.41M |
| February 23, 2024 | 725.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
269.99M
Minimum
Nov 09 2023
3.347B
Maximum
May 03 2024
763.40M
Average
593.31M
Median
Market Cap Benchmarks
| Viking Therapeutics Inc | 8.275B |
| Equillium Inc | 63.81M |
| Minerva Neurosciences Inc | 16.50M |
| Arvinas Inc | 2.178B |
| Calidi Biotherapeutics Inc | 8.039M |
Market Cap Related Metrics
| PS Ratio | 340.81 |
| Price to Book Value | 9.391 |
| Price | 62.60 |
| Earnings Yield | -2.12% |